Skip to Content

Calamos International Growth I CIGIX

Medalist Rating as of | See Calamos Investment Hub
  • NAV / 1-Day Return 22.41  /  −0.04 %
  • Total Assets 243.5 Mil
  • Adj. Expense Ratio
    0.950%
  • Expense Ratio 0.950%
  • Distribution Fee Level Above Average
  • Share Class Type Institutional
  • Category Foreign Large Growth
  • Investment Style Large Growth
  • Min. Initial Investment 1.0 Mil
  • Status Open
  • TTM Yield 0.25%
  • Turnover 131%

USD | NAV as of Mar 27, 2024 | 1-Day Return as of Mar 27, 2024, 10:07 PM GMT+0

Morningstar’s Analysis CIGIX

Will CIGIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin Calamos International Growth I's Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings CIGIX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 33.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S Class B

6.23 14.1 Mil
Healthcare

ASML Holding NV

3.87 8.7 Mil
Technology

Advantest Corp

3.70 8.4 Mil
Technology

Rolls-Royce Holdings PLC

3.48 7.8 Mil
Industrials

Shopify Inc Registered Shs -A- Subord Vtg

3.07 6.9 Mil
Technology

Taiwan Semiconductor Manufacturing Co Ltd

2.89 6.5 Mil
Technology

Constellation Software Inc

2.73 6.1 Mil
Technology

Gerresheimer AG

2.61 5.9 Mil
Healthcare

MercadoLibre Inc

2.59 5.8 Mil
Consumer Cyclical

SAP SE

2.58 5.8 Mil
Technology